Impact Medicom công khai
[search 0]
Thêm

Download the App!

show episodes
 
We are a medical communications company with a passion for developing high-quality content. We write & design content for healthcare professionals and patients in a variety of therapeutic areas. If you like our podcast, please take the time to rate it and subscribe. See our website for more information, Webinars, and podcasts at: https://www.impactmedicom.com.
 
Loading …
show series
 
In this episode, we discuss immunotherapy treatment and biomarker testing for metastatic cervical cancer. Our Guest: Dr. James Bentley is a Professor and Head of the Department of Obstetrics and Gynecology at Dalhousie University, Halifax, Canada. Dr. Bentley is Past President of the International Federation of Cervical Pathology and Colposcopy (IF…
 
In this episode of IMPACT Medicom’s podcast series on immunotherapies in Head and Neck Squamous Cell Carcinoma, we discuss the medical oncologist’s role in managing patients with HNSCC, and how immunotherapies fit in to their practice. Our Guest: Dr. Martin Smoragiewicz is a Medical Oncologist at the Odette Cancer Centre, part of Sunnybrook Health …
 
Welcome to episode 11 of our Precision Medicine in Oncology series. In this episode, we discuss the development of a pan-Canadian consensus paper on the selection and use of PARP inhibitors for first-line maintenance treatment in ovarian cancer. Our Guest: Our guest for this episode is Dr. Anna Tinker, Medical Oncologist at BC Cancer in Vancouver, …
 
Welcome to the second episode of IMPACT Medicom’s podcast series on Immunotherapy in Head and Neck Squamous Cell Carcinomas (HNSCC). This episode includes a discussion of: The role of the surgical oncologist in managing patients with HNSCC How immunotherapy fits into to the surgical oncologist's practice Our Guest: Our guest is Dr. Antoine Eskander…
 
Welcome to the first episode of IMPACT Medicom’s podcast series on Immunotherapy in Head and Neck Squamous Cell Carcinomas. This episode includes a discussion of: The role of the pathologist in the management of head and neck cancers PD-L1 testing as a predictive biomarker for immunotherapy in HNSCC Improving the testing process for PD-L1 Our Guest…
 
In this episode, we discuss the treatment of triple negative breast cancer (TNBC) with Dr. Stephen Chia. We cover: The use of immunotherapies to treat TNBC Biomarkers that can determine which patients will best respond to immunotherapies The challenges of testing for PDL-1 Our Guest: Dr. Stephen Chia is a professor in the division of medical oncolo…
 
Bienvenue à la série de fichiers balados d’IMPACT Medicom sur la vaccination contre la COVID-19. Roula Drossis est l’animatrice de l’épisode d’aujourd’hui. Dans cet épisode, nous discutons de l'immunisation contre la COVID-19 et de la façon dont nous pouvons protéger nos populations les plus vulnérables qui ne sont pas en mesure de produire une rép…
 
In this podcast series on pre- and post- COVID-19 prophylaxis, we discuss immunization against COVID-19 and how we can protect our most vulnerable populations who are not able to mount a sufficient antibody response to vaccination. In this fourth episode of the series, we discuss: Response to COVID-19 vaccines in the general population Response to …
 
In this podcast series on pre- and post- COVID-19 prophylaxis, we discuss immunization against COVID-19 and how we can protect our most vulnerable populations who are not able to mount a sufficient antibody response to vaccination. In this third episode of the series, we discuss: Response to COVID-19 vaccines in the general population Response to C…
 
In this podcast series on pre- and post- COVID-19 prophylaxis, we discuss immunization against COVID-19 and how we can protect our most vulnerable populations who are not able to mount a sufficient antibody response to vaccination. In this first episode of the series, we discuss: Response to COVID-19 vaccines in the general population Populations w…
 
In this podcast series on pre- and post- COVID-19 prophylaxis, we discuss immunization against COVID-19 and how we can protect our most vulnerable populations who are not able to mount a sufficient antibody response to vaccination. In this second episode of the series, we discuss: Response to COVID-19 vaccines in the general population Response to …
 
In this episode of IMPACT Medicom’s Precision Medicine in Oncology podcast series, we discuss the evolving biomarker landscape in gastrointestinal malignancies and some of the advantages and challenges of implementing and accessing biomarker testing. Our guest: Dr. Rosalyn Juergens is a medical oncologist with clinical expertise in lung and esophag…
 
Welcome to episode 9 of IMPACT Medicom’s podcast series on Precision Medicine in Oncology, the second episode in a 3-part series on ovarian cancer. This episode, hosted by IMPACT Medicom’s Sarah Doucette, features a debate on whether first-line maintenance therapy with PARP inhibitors can be considered a curative strategy in patients with advanced,…
 
Welcome to episode 8 of IMPACT Medicom’s podcast series on Precision Medicine in Oncology, the first in a series of episodes focusing on ovarian cancer. In this episode, we discuss the importance of BRCA testing for patients with advanced epithelial ovarian cancer and how national initiatives have helped to improve BRCA testing standards across the…
 
In this seventh episode of our podcast series on precision medicine, hosted by Anna Christofides, we discuss genomic testing in prostate cancer. Our episode focuses on the evolution and uptake of genetic testing in prostate cancer. We discuss testing for homologous recombination repair (HRR) genes and their association with prognosis and influence …
 
Welcome to episode 6 of IMPACT Medicom’s podcast series on Precision Medicine in Oncology. In this episode Dr. Gonzalez discusses testing methodology, particularly for mismatch repair deficiency, as well as potential emerging biomarkers for metastatic colorectal cancer. Our Guest: Dr. Raul Gonzalez is an Associate Professor of Pathology at Harvard …
 
In this episode of our podcast, we discuss the use of zanubrutinib for the treatment of Waldenstrom’s Macroglobulinemia. Our episode discusses data from the Phase 3 ASPEN trial, comparing the efficacy and safety of zanubrutinib with ibrutinib in these patients. Our Guests Our first guest, Dr. Constantine Tam, is a Professor of Hematology at the Uni…
 
In this episode of IMPACT Medicom’s podcast series on Precision Medicine in Oncology we discuss: · The current standards for molecular testing in metastatic colorectal cancer · The potential benefit of a Canadian guideline for molecular testing in metastatic colorectal cancer Our guest: Dr. Sharlene Gill is Professor of Medicine at the University o…
 
Background Lung cancer is one of the most common cancers and is the leading cause of cancer death in Canada. (2020 Canadian Cancer Statistics) Survival from lung cancer is poor. Three-year net survival for lung cancer decreased from 71% among those diagnosed at stage 1 to 5% among those diagnosed at stage 4. Approximately half of all lung cancer ca…
 
Background Lung cancer is one of the most common cancers and is the leading cause of cancer death in Canada. (2020 Canadian Cancer Statistics) Survival from lung cancer is poor. Three-year net survival for lung cancer decreased from 71% among those diagnosed at stage 1 to 5% among those diagnosed at stage 4. Approximately half of all lung cancer ca…
 
Renseignements généraux Le cancer du poumon est l’une des formes de cancer les plus courantes ainsi que la principale cause de décès par cancer au Canada. (Statistiques canadiennes sur le cancer, 2020). Le taux de survie des patients atteints d’un cancer du poumon est faible. La survie nette à trois ans est de 71 % pour les cas diagnostiqués au sta…
 
Background Lung cancer is one of the most common cancers and is the leading cause of cancer death in Canada. (2020 Canadian Cancer Statistics) Survival from lung cancer is poor. Three-year net survival for lung cancer decreased from 71% among those diagnosed at stage 1 to 5% among those diagnosed at stage 4. Approximately half of all lung cancer ca…
 
In this episode of IMPACT Medicom’s podcast series on Precision Medicine in Oncology we discuss: · The initiatives developed by Colorectal Cancer Canada to help progress access to genomic profiling and precision medicine for all cancer patients · The patient’s perspective on education, access, and value of genomic profiling · Access to genomic prof…
 
In this episode of our podcast, we are joined by a very special guest, Dr. John Kuruvilla, who is an Associate Professor of Medicine at the University of Toronto and a Clinical Investigator in the Division of Medical Oncology and Hematology at Princess Margaret Hospital in Toronto. We discuss: The current treatment of classical Hodgkin’s Lymphoma T…
 
Welcome to IMPACT Medicom’s MYTHBUSTER series, addressing COVID-19 vaccine hesitancy. This series is aimed at health care professionals who are on the front lines of vaccine delivery, to help address common sources of misinformation around COVID-19 vaccines. In the third episode of the series, hosted by Anna Christofides (owner of IMPACT Medicom), …
 
Podcast details: In this episode of IMPACT Medicom’s podcast series on Precision Medicine in Oncology we discuss: · The evolving role of genomics in a pathologist’s tool kit for informing care in oncology · The value of comprehensive genomic profiling (CGP) compared to single-gene tests · The barriers to accessing CGP in Ontario · What factors inst…
 
Welcome to IMPACT Medicom’s MYTHBUSTER series, addressing COVID-19 vaccine hesitancy. This series is aimed at health care professionals who are on the front lines of vaccine delivery, to help address common sources of misinformation around COVID-19 vaccines. In the second episode of the series, hosted by Anna Christofides (owner of IMPACT Medicom),…
 
Welcome to IMPACT Medicom’s MYTHBUSTER series, addressing COVID-19 vaccine hesitancy. This series is aimed at health care professionals who are on the front lines of vaccine delivery, to help address common sources of misinformation around COVID-19 vaccines. In the second part of the first episode of the series, hosted by Anna Christofides (owner o…
 
Welcome to IMPACT Medicom’s MYTHBUSTER series, addressing COVID-19 vaccine hesitancy. This series is aimed at health care professionals who are on the front lines of vaccine delivery, to help address common sources of misinformation around COVID-19 vaccines. In our first episode of the series, hosted by Anna Christofides (owner of IMPACT Medicom), …
 
In this episode of IMPACT Medicom’s podcast series on Precision Medicine in Oncology we discuss: · The BC OncoPanel, a comprehensive genomic profiling (CGP) test available to patients with some cancers in British Columbia; · The challenges for including CGP in laboratory budgets; · The information exchange needed between stakeholders to accelerate …
 
Welcome to our podcast series on precision medicine in oncology. In this first episode of the series, we discuss the importance of comprehensive genomic profiling (CGP) as a critical tool for treating patients with advanced solid tumors. Included is a discussion of: The CGP report, which is designed to aid Canadian decision makers in the prioritiza…
 
In this episode, we discuss the use of Bruton’s Tyrosine Kinase (BTK) inhibitors for the treatment of patients with chronic lymphocytic leukemia (CLL). Included is a discussion of: Novel treatments for CLL The impact of BTK inhibitors for the treatment of CLL The differences between first- (e.g. ibrutinib) and second-generation (e.g. acalabrutinib,…
 
In this episode we discuss the management of CLL patients during the COVID-19 pandemic. Included is a discussion of: The initial treatment of patients with CLL during COVID-19 The use of BTK inhibitors vs FCR The use of intravenous or subcutaneous immunoglobulin Existing guidelines for the treatment of CLL during COVID-19 The virtual management of …
 
On today’s podcast episode, we discuss the virtual management of patients with inflammatory arthritis. We are joined by: Dr. Janet Pope: Professor of Medicine in the Division of Rheumatology, Epidemiology and Biostatistics at the University of Western Ontario. Our episode includes a discussion of: The use of a virtual platform for managing patients…
 
In this episode, we discuss the opioid epidemic in Canada and the use of naloxone, a life-saving drug that is used to prevent death from opioid overdose, with pharmacists: Dr. Ross Tsuyuki and Mark Barnes. Dr. Ross Tsuyuki - professor and chair of the Department of Pharmacology in the Faculty of Medicine and Dentistry at the University of Alberta. …
 
Dr. Ray Deonandan is a Canadian epidemiologist, assistant director, and associate professor at the University of Ottawa. In this episode, we discuss how we can exercise safely during the COVID-19 epidemic as the cold weather approaches. The importance of exercise for physical and mental health is discussed as well as tips for reducing the chance of…
 
Loading …

Hướng dẫn sử dụng nhanh

Google login Twitter login Classic login